Literature DB >> 26593132

Cellular Players in the Immunopathogenesis of Sarcoidosis.

Gernot Zissel1, Joachim Müller-Quernheim2.   

Abstract

Current hypotheses on the pathogenesis of sarcoidosis assume that it is induced by a nondegradable antigen inducing immune reactions, which are mediated by a panel of immune cells of the innate and adoptive immune system. This immune reaction leads to an accumulation of immune cells that is mainly alveolar macrophages, T cells, and neutrophils in the lung. As the antigen persists and cannot be eliminated, the ongoing immune reaction results in granuloma formation and remodeling of the lung. The current review aims to elucidate the different roles of the cellular players in the immunopathogenesis of sarcoidosis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alveolar macrophage; Cytokines; Saracoidosis; T cells; TH1; TH17; TNF; Treg

Mesh:

Substances:

Year:  2015        PMID: 26593132     DOI: 10.1016/j.ccm.2015.08.016

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  14 in total

Review 1.  Potential immunotherapies for sarcoidosis.

Authors:  Van Le; Elliott D Crouser
Journal:  Expert Opin Biol Ther       Date:  2018-01-17       Impact factor: 4.388

2.  High throughput 16SrRNA gene sequencing reveals the correlation between Propionibacterium acnes and sarcoidosis.

Authors:  Meng-Meng Zhao; Shan-Shan Du; Qiu-Hong Li; Tao Chen; Hui Qiu; Qin Wu; Shan-Shan Chen; Ying Zhou; Yuan Zhang; Yang Hu; Yi-Liang Su; Li Shen; Fen Zhang; Dong Weng; Hui-Ping Li
Journal:  Respir Res       Date:  2017-02-01

Review 3.  Pulmonary Extracellular Vesicles as Mediators of Local and Systemic Inflammation.

Authors:  Casper J E Wahlund; Anders Eklund; Johan Grunewald; Susanne Gabrielsson
Journal:  Front Cell Dev Biol       Date:  2017-04-26

4.  Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression.

Authors:  Monika Linke; Ha Thi Thanh Pham; Karl Katholnig; Thomas Schnöller; Anne Miller; Florian Demel; Birgit Schütz; Margit Rosner; Boris Kovacic; Nyamdelger Sukhbaatar; Birgit Niederreiter; Stephan Blüml; Peter Kuess; Veronika Sexl; Mathias Müller; Mario Mikula; Wolfram Weckwerth; Arvand Haschemi; Martin Susani; Markus Hengstschläger; Michael J Gambello; Thomas Weichhart
Journal:  Nat Immunol       Date:  2017-01-16       Impact factor: 25.606

Review 5.  Refractory Sarcoidosis: A Review.

Authors:  Thomas El Jammal; Yvan Jamilloux; Mathieu Gerfaud-Valentin; Dominique Valeyre; Pascal Sève
Journal:  Ther Clin Risk Manag       Date:  2020-04-17       Impact factor: 2.423

6.  Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) - protocol for a multi-center, single-arm phase IIa trial.

Authors:  Björn C Frye; Ina Caroline Rump; Annette Uhlmann; Fabian Schubach; Gabriele Ihorst; Bodo Grimbacher; Gernot Zissel; Joachim Müller Quernheim
Journal:  Contemp Clin Trials Commun       Date:  2020-05-29

7.  Mapping mononuclear phagocytes in blood, lungs, and lymph nodes of sarcoidosis patients.

Authors:  Rico Lepzien; Gregory Rankin; Jamshid Pourazar; Ala Muala; Anders Eklund; Johan Grunewald; Anders Blomberg; Anna Smed-Sörensen
Journal:  J Leukoc Biol       Date:  2019-02-11       Impact factor: 4.962

Review 8.  Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects.

Authors:  Raisa Kraaijvanger; Montse Janssen Bonás; Adriane D M Vorselaars; Marcel Veltkamp
Journal:  Front Immunol       Date:  2020-07-14       Impact factor: 7.561

9.  Can pulmonary sarcoidosis trigger a progressive multifocal leukoencephalopathy? Considerations from a case series and a review of literature.

Authors:  Irene Gamperl; Christian Enzinger; Alexander Pichler; Michael Feichtinger; Thomas Schlager; Elisabeth Fertl
Journal:  Clin Case Rep       Date:  2018-09-21

10.  Novel protein pathways in development and progression of pulmonary sarcoidosis.

Authors:  Maneesh Bhargava; K J Viken; B Barkes; T J Griffin; M Gillespie; P D Jagtap; R Sajulga; E J Peterson; H E Dincer; L Li; C I Restrepo; B P O'Connor; T E Fingerlin; D M Perlman; L A Maier
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.